Pricing Analytics Guide OTC Brands Out Of Private Label Trap
This article was originally published in The Tan Sheet
Executive Summary
Brands should focus on building their equity and innovating to differentiate from private label, Marketing Management Analytics says in an interview. MMA works with clients such as GlaxoSmithKline to optimize retail pricing for OTC drugs and supplements based on pricing analytics and predictive modeling.
You may also be interested in...
Celebrity Endorsers “Shine A Spotlight” But Bring Costs, Risks
Celebrity endorsers can "create an emotional bridge" between consumers and brands, among other benefits, but they also pose risks and may not be cost-effective or appropriate for OTC and supplement products.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.